These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 20609865

  • 1. The complex clinical picture of side effects to anticoagulation.
    Trautmann A, Seitz CS.
    Med Clin North Am; 2010 Jul; 94(4):821-34, xii-iii. PubMed ID: 20609865
    [Abstract] [Full Text] [Related]

  • 2. Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection.
    Trautmann A, Seitz CS.
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):469-80. PubMed ID: 19563992
    [Abstract] [Full Text] [Related]

  • 3. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
    Gaigl Z, Pfeuffer P, Raith P, Bröcker EB, Trautmann A.
    Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
    [Abstract] [Full Text] [Related]

  • 4. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
    Koch P.
    Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
    [Abstract] [Full Text] [Related]

  • 5. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update.
    Jappe U.
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):605-13. PubMed ID: 17102645
    [Abstract] [Full Text] [Related]

  • 6. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
    Ludwig RJ, Schindewolf M, Alban S, Kaufmann R, Lindhoff-Last E, Boehncke WH.
    Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404
    [Abstract] [Full Text] [Related]

  • 7. [-Anticoagulant drugs-].
    Gulba DC.
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [Abstract] [Full Text] [Related]

  • 8. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight.
    Grims RH, Weger W, Reiter H, Arbab E, Kränke B, Aberer W.
    Br J Dermatol; 2007 Sep; 157(3):514-7. PubMed ID: 17573880
    [Abstract] [Full Text] [Related]

  • 9. [Cutaneous delayed hypersensitivity reactions to heparins and heparinoids].
    Figarella I, Barbaud A, Lecompte T, De Maistre E, Reichert-Penetrat S, Schmutz JL.
    Ann Dermatol Venereol; 2001 Jan; 128(1):25-30. PubMed ID: 11226896
    [Abstract] [Full Text] [Related]

  • 10. Heparin-induced skin necrosis and low molecular weight heparins.
    Drew PJ, Smith MJ, Milling MA.
    Ann R Coll Surg Engl; 1999 Jul; 81(4):266-9. PubMed ID: 10615196
    [Abstract] [Full Text] [Related]

  • 11. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids.
    Schiffner R, Glässl A, Landthaler M, Stolz W.
    Contact Dermatitis; 2000 Jan; 42(1):49. PubMed ID: 10644031
    [No Abstract] [Full Text] [Related]

  • 12. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases.
    Jappe U, Juschka U, Kuner N, Hausen BM, Krohn K.
    Contact Dermatitis; 2004 Aug; 51(2):67-72. PubMed ID: 15373846
    [Abstract] [Full Text] [Related]

  • 13. Widespread skin necrosis associated with unfractionated heparin therapy in a patient under chronic coumarin anticoagulation.
    Sanchez-Politta S, Angelillo-Scherrer A, Masouyé I, Borradori L.
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):327-30. PubMed ID: 16503898
    [Abstract] [Full Text] [Related]

  • 14. [Skin necrosis: a paradoxical complication of anticoagulation].
    Balestra B.
    Schweiz Med Wochenschr; 1995 Feb 25; 125(8):361-4. PubMed ID: 7709185
    [Abstract] [Full Text] [Related]

  • 15. [Management of heparin-induced thrombocytopenia].
    Aouizerate P, Guizard M.
    Therapie; 2002 Feb 25; 57(6):577-88. PubMed ID: 12666266
    [Abstract] [Full Text] [Related]

  • 16. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
    Irion R, Gall H, Peter RU.
    Contact Dermatitis; 2000 Oct 25; 43(4):249-50. PubMed ID: 11011948
    [No Abstract] [Full Text] [Related]

  • 17. Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
    Menajovsky LB.
    Am J Med; 2005 Aug 25; 118 Suppl 8A():21S-30S. PubMed ID: 16125511
    [Abstract] [Full Text] [Related]

  • 18. [Heparin induced thrombocytopenia type II after the use of low-molecular weight heparin. Case report and review of the literature].
    Franke J, Schaeper O, Kayser R, Mahlfeld K.
    Unfallchirurg; 2003 Jan 25; 106(1):77-81. PubMed ID: 12552397
    [Abstract] [Full Text] [Related]

  • 19. [A study of 19 cases of allergy to heparins with positive skin testing].
    Phan C, Vial-Dupuy A, Autegarden JE, Amsler E, Gaouar H, Abuaf N, Pecquet C, Francès C, Soria A.
    Ann Dermatol Venereol; 2014 Jan 25; 141(1):23-9. PubMed ID: 24461090
    [Abstract] [Full Text] [Related]

  • 20. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
    Nowak G, Bucha E, Brauns I, Czerwinski R.
    Wien Klin Wochenschr; 1997 May 23; 109(10):354-8. PubMed ID: 9200807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.